Changes in ratio of ineligible use of lamotrigine in Japan based on data from the relief system of the Pharmaceuticals and Medical Devices Agency.
Kensuke UsuiKazuo YamadaKouji OkadaRyusuke OuchiMasashi NibuyaAi TakahashiYuzo ShitoYoshiteru WatanabeHidehisa SaekiEiji SuzukiPublished in: Psychiatry and clinical neurosciences (2020)